Tanvex BioPharma Statistics
Total Valuation
TPE:6541 has a market cap or net worth of TWD 12.09 billion. The enterprise value is 13.06 billion.
Market Cap | 12.09B |
Enterprise Value | 13.06B |
Important Dates
The next estimated earnings date is Friday, November 7, 2025.
Earnings Date | Nov 7, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
TPE:6541 has 238.49 million shares outstanding. The number of shares has increased by 40.86% in one year.
Current Share Class | 238.49M |
Shares Outstanding | 238.49M |
Shares Change (YoY) | +40.86% |
Shares Change (QoQ) | +6.24% |
Owned by Insiders (%) | 1.21% |
Owned by Institutions (%) | 2.02% |
Float | 84.46M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 108.94 |
PB Ratio | 2.48 |
P/TBV Ratio | 7.42 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -9.31 |
EV / Sales | 117.63 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -10.42 |
Financial Position
The company has a current ratio of 2.17, with a Debt / Equity ratio of 0.32.
Current Ratio | 2.17 |
Quick Ratio | 1.41 |
Debt / Equity | 0.32 |
Debt / EBITDA | n/a |
Debt / FCF | -1.23 |
Interest Coverage | -26.32 |
Financial Efficiency
Return on equity (ROE) is -44.17% and return on invested capital (ROIC) is -16.88%.
Return on Equity (ROE) | -44.17% |
Return on Assets (ROA) | -15.80% |
Return on Invested Capital (ROIC) | -16.88% |
Return on Capital Employed (ROCE) | -20.47% |
Revenue Per Employee | 560,576 |
Profits Per Employee | -7.08M |
Employee Count | 198 |
Asset Turnover | 0.02 |
Inventory Turnover | 0.67 |
Taxes
Income Tax | -3.02M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -26.50% in the last 52 weeks. The beta is 0.03, so TPE:6541's price volatility has been lower than the market average.
Beta (5Y) | 0.03 |
52-Week Price Change | -26.50% |
50-Day Moving Average | 53.19 |
200-Day Moving Average | 60.87 |
Relative Strength Index (RSI) | 40.74 |
Average Volume (20 Days) | 832,408 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPE:6541 had revenue of TWD 110.99 million and -1.40 billion in losses. Loss per share was -7.11.
Revenue | 110.99M |
Gross Profit | -26.62M |
Operating Income | -1.30B |
Pretax Income | -1.41B |
Net Income | -1.40B |
EBITDA | -1.15B |
EBIT | -1.30B |
Loss Per Share | -7.11 |
Balance Sheet
The company has 570.97 million in cash and 1.54 billion in debt, giving a net cash position of -964.41 million or -4.04 per share.
Cash & Cash Equivalents | 570.97M |
Total Debt | 1.54B |
Net Cash | -964.41M |
Net Cash Per Share | -4.04 |
Equity (Book Value) | 4.87B |
Book Value Per Share | 20.42 |
Working Capital | 637.55M |
Cash Flow
In the last 12 months, operating cash flow was -1.13 billion and capital expenditures -118.46 million, giving a free cash flow of -1.25 billion.
Operating Cash Flow | -1.13B |
Capital Expenditures | -118.46M |
Free Cash Flow | -1.25B |
FCF Per Share | -5.25 |
Margins
Gross Margin | -23.99% |
Operating Margin | -1,171.31% |
Pretax Margin | -1,266.56% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
TPE:6541 does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -40.86% |
Shareholder Yield | n/a |
Earnings Yield | -11.60% |
FCF Yield | -10.36% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on March 2, 2023. It was a reverse split with a ratio of 0.3335779572.
Last Split Date | Mar 2, 2023 |
Split Type | Reverse |
Split Ratio | 0.3335779572 |
Scores
TPE:6541 has an Altman Z-Score of 0.14 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 0.14 |
Piotroski F-Score | 2 |